Amber Lynae Reynolds-lorentz, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 221 E 10th St, Ogallala, NE 69153 Phone: 308-284-8421 Fax: 308-284-2821 |
Carol Mary Packard, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 221 E 10th St, Ogallala, NE 69153 Phone: 308-284-8421 |
Mara Peters, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2601 N Spruce St, Ogallala, NE 69153 Phone: 308-284-4011 |
Mrs. Monica Rachelle Patin, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2601 N Spruce St, Ogallala, NE 69153 Phone: 308-284-3645 Fax: 308-284-2721 |
Crystal Lynn Orr, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2601 N Spruce St, Ogallala, NE 69153 Phone: 308-284-3645 |
News Archive
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
Scientists have discovered an enzyme used in nature to make powerful chemicals from catnip to a cancer drug, vinblastine. The discovery opens up the prospect of producing these chemicals cheaply and efficiently.
A study from the Chinese Academy of Social Sciences (CASS), a government-backed institution, has found that "China's 'one couple, one child' family planning policy" has resulted in a gender imbalance that is the "most serious demographic problem facing" the country, the Times of London reports.
Despite national guidelines recommending that inhaled corticosteroid (ICS) be used alone as the preferred treatment for patients with mild persistent asthma, a new study finds that nearly two-thirds of these patients are taking more costly drugs that combine an ICS and a long-acting beta agonist (LABA) with no apparent additional clinical benefit noted based on pharmacy and medical claims.
› Verified 4 days ago